MAP vs RGT

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

MAP

MICROBA FPO [MAP]

46LOW

RGT

ARGENTBIO FPO [RGT]

43LOW

Score Breakdown

MAP RGT
Technical
66
35
Catalyst
54
51
Sentiment
50
50
Fundamental
66
34
Momentum
30
44
Risk Gate
45
32

Key Metrics

MAP Metric RGT
$31.5MMarket Cap$5.4M
1.1MAvg Volume (20d)1.2M
N/AShort InterestN/A
$0.10552-Week High$0.320
$0.03652-Week Low$0.033
+7.1%Daily Change-7.4%
$0.045Reference Price$0.050
-60.0%ROEN/A
-132.5%Profit MarginN/A

Active Signals

MAP Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Knocking on the door of resistance — if it punches through, things could get interesting
●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (3 quarters) - dilution risk
●4C filed 2026-07-15

RGT Signals

●MACD momentum is losing steam
●Took a hit — down 16.7% over the last 5 days
●Beating the Small Ords index — relative strength of 1.41, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.8 quarters)
●Strong revenue growth (+3905%)
●Piotroski F-Score weak (2/9, low-confidence approx)
●Near 52-week low (5% of range)

Ask Scout AI to compare MAP and RGT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MAP vs RHY →MAP vs SPL →MAP vs VBS →MEM vs MSB →MEM vs NEU →
MAP Full Analysis → RGT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).